| Literature DB >> 23883361 |
Ingvild Vistad, Milada Cvancarova, Berit L Hustad, Tore Henriksen.
Abstract
BACKGROUND: Most countries recommend planned cesarean section in breech deliveries, which is considered safer than vaginal delivery. As one of few countries in the western world Norway has continued to practice planned vaginal delivery in selected women. The aim of this study is to evaluate prospectively registered neonatal and maternal outcomes in term singleton breech deliveries in a Norwegian hospital during a ten years period. We aim to compare maternal and neonatal outcomes in term breech pregnancies subjected either to planned vaginal or elective cesarean section.Entities:
Mesh:
Year: 2013 PMID: 23883361 PMCID: PMC3728003 DOI: 10.1186/1471-2393-13-153
Source DB: PubMed Journal: BMC Pregnancy Childbirth ISSN: 1471-2393 Impact factor: 3.007
Figure 1Study flow chart.
Maternal and obstetric outcomes in the planned cesarean and planned vaginal delivery groups
| Median (range) maternal age (years) | 29 (19–42) | 29 (16–43) | NS |
| Parity | | | |
| Nulliparous | 154/279 | 152/289 | |
| Multiparous | 125/279 | 137/289 | NS |
| Mean gestational age | 38.7 | 39.4 | |
| Mean birth weight (g) | 3531 | 3399 | <0.01 |
| ≥ 4000 | 50/279 (18%) | 32/289 (11%) | |
| < 4000 | 229/279 (82%) | 257/289 (89%) | 0.02 |
| Pelvimetry performed | 111 (55%) | 131 (60%) | 0.18 |
| Reasons for planned cesarean section | Fetopelvic disproportion 85 (35%) | 0 | |
| ≥ two cesarean sections 7 (3%) | 0 | ||
| Patients’ request 101 (41%) | 0 | ||
| Maternal disease 20 (8%) | 0 | ||
| Former obstetric complic. 5 (2%) | 0 | ||
| Other reasons 28 (11%) | 0 | ||
| Reasons for acute cesarean section | Planned cesarean section 33 (24%) | Fetal malposition* 33 (24%) | |
| Failure to progress 20 (15%) | |||
| Fetal distress 18 (13%) | |||
| Maternal disease 4 (3%) | |||
| Undiagnosed breech 11 (8%) | |||
| (patient’s request) | |||
| Other reasons 18 (13%) |
*Incomplete breech or footling presentation.
Fetal outcomes in the planned cesarean and planned vaginal delivery groups
| 5-min Apgar < 7 | 0 | 7 | <0.01 |
| 5-min Apgar < 4 | 0 | 1 | NA |
| Transfer to NICU* < 4 days | 8 | 29 | <0.01 |
| NICU ≥ 4 days | 0 | 1 | NA |
| SGA** | 25 | 51 | <0.01 |
| SGA babies transferred to NICU | 2 | 9 | 0.26 |
| Fetal birth injury | 0 | 1 | NA |
| Umbilical artery pH < 7.00 | 0 (N = 19) | 5 (N = 130) | NA |
*Neonatal intensive care unit; **Small for gestational age.
Management of labor and delivery in 185 vaginal births
| Induction of labor | 3 (1.6) |
| Prostaglandins | 2 |
| Oxytocin | 1 |
| Augmentation of labor | 148 (80.0) |
| Oxytocin | 139 (75.1) |
| Amniotomy | 9 (4.9) |
| Duration of labor (>4 cm dilatation) | |
| < 4 h | 44 (24.6) |
| 4–6 h | 70 (39.1) |
| > 7 h | 65 (36.3) |
| Duration of active pushing | |
| < 30 min | 147 (81.7) |
| 30–59 min | 31 (17.2) |
| > 60 min | 2 (1.1) |
| Station at beginning of active pushing | |
| High | 12 (6.5) |
| Mid | 47 (25.4) |
| Low | 126 (68.1) |
| Pain-relief during labor | |
| Epidural | 94 (50.8) |
| Fentanyl | 43 (23.2) |
| Pudendal nerve block | 8 (4.3) |
| Pethedin | 4 (2.2) |
| STAN* | 56 (30.3) |
*ST Waveform Analysis initiated in 2003.